Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study
Most Cited Paper
in Pediatric health and respiratory diseases
18 Months Post-Publication
Class of 2026
“Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026/
Topics
Dupilumab · Eosinophilic asthma · Clinical remission · biological therapy for type 2 asthma · oral corticosteroid (OCS) dependence · OCS dose reduction · Asthma exacerbations · asthma control test (ACT) score · pre-bronchodilator FEV1 · Fractional exhaled nitric oxide (FeNO) · Blood eosinophil count · FEF25-75% small airway flow · Real-world evidence · long-term follow-up (24 months) · obesity as predictor of treatment response · odds ratio for clinical remission · complete vs partial remission · type 2 inflammation biomarkers · baseline clinical characteristics as predictors · IL-4/IL-13 pathway blockade
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459